about the author

ENDPOINTS

editor@endpointsnews.com

author articles

As­traZeneca, Mer­ck score Chi­na OK for Lyn­parza; Re­gen­eron spot­lights mid-stage da­ta for rare dis­ease drug

6 years ago
News Briefing

Japan­ese biotech pitch­ing iP­SC-de­rived med for the heart gains $26M; An­dreessen Horowitz leads $4.1M seed fund­ing for ...

6 years ago
News Briefing

Ab­bott Lab­o­ra­to­ries CEO Miles White pass­es ba­ton down to suc­ces­sor; Lon­za CEO Marc Funk hits the ex­it

6 years ago
Peer Review

Seat­tle and Dai­ichi Sankyo at each oth­er's throats; UC Berke­ley, UCSF and the Uni­ver­si­ty of Wash­ing­ton launch Weill ...

6 years ago
News Briefing

Te­va spin­out rais­es $85M in IPO; No­var­tis beefs up gener­ics unit with $440M deal

6 years ago
News Briefing

Spe­cial re­port: Twen­ty ex­tra­or­di­nary women in bio­phar­ma R&D who worked their way to the top

6 years ago
People
Special

An­ces­tryD­NA chief takes on liq­uid biop­sy chal­lenge; Thomas Lynch chairs for­mer col­league's can­cer start­up

6 years ago
Peer Review

Gilead­'s ex-in­vestor re­la­tions chief takes CFO job at Sang­amo; For­mer GE Health­care ex­ec takes the helm at Vec­tura ...

6 years ago
Peer Review

Christo­pher Haqq joins Eli­cio to hunt fa­ther's RAS can­cer; Kro­nos ex­pands top team with Gilead, Bay­lor vets

6 years ago
Peer Review

Drug com­pa­nies reach $260M set­tle­ment just ahead of opi­oid tri­al; Oys­ter Point set terms for $85M IPO

6 years ago
News Briefing

Ronald Herb­st fol­lows Med­Im­mune ex­o­dus to Pyx­is CSO post; Jeff God­dard to suc­ceed CEO of AIT Bio­science

6 years ago
Peer Review

FDA re­quests ad­di­tion­al time for Flex­ion's sN­DA; Genen­tech re­leas­es da­ta for PhI­II study of Rit­ux­an

6 years ago
News Briefing

North­west Bio still hang­ing on; Five Prime's lat­est round of lay­offs claims 70

6 years ago
News Briefing

Zosano Phar­ma CEO pass­es ba­ton down to suc­ces­sor; James Sapirstein takes the helm at Azur­Rx

6 years ago
Peer Review

Pro­lif­ic In­sil­i­co scores up to $200M deal in Chi­na; Re­searchers re­tract pa­per on gene in­volved in CRISPR ba­by ...

6 years ago
News Briefing

FDA ap­proves drug for rare con­di­tion that trig­gers in­tense pain from light ex­po­sure

6 years ago
R&D
FDA+

DB­V's peanut al­ler­gy patch is fi­nal­ly un­der FDA re­view; Rit­ter swal­lows bit­ter pill to ex­plore strate­gic al­ter­na­tives

6 years ago
News Briefing

NICE fails to en­dorse Roche's Tecen­triq for breast can­cer; Eli­cio clos­es fi­nanc­ing round with $33M

6 years ago
News Briefing

For­mer Akcea pres­i­dent makes the leap to CEO seat at Avid­i­ty Bio­sciences; Astel­las in­vests $12.5M in­to two in­cu­ba­tors

6 years ago
News Briefing

Chris Roberts jumps back in­to biotech with CSO gig at Black Di­a­mond; Trou­bled Five Prime ap­points in­ter­im CEO

6 years ago
Peer Review

Am­gen inks dis­cov­ery deal with Hum­ming­bird; Mer­ck gains pri­or­i­ty re­view for Ebo­la vac­cine

6 years ago
News Briefing

As­traZeneca's di­a­betes drug grant­ed fast track des­ig­na­tion for heart fail­ure; Ver­ri­ca sends skin in­fec­tion treat­ment ...

6 years ago
News Briefing

Wood­ford forced to write down val­ues of hold­ings; No­var­tis show­cas­es pos­i­tive PhI­II MS da­ta

6 years ago
News Briefing

Alex Ar­faei trades his an­a­lyst's post for a new role as biotech VC; Sanofi vet heads to Vi­for

6 years ago
Peer Review
First page Previous page 15161718192021 Next page Last page
A service from the Financial Times